An article (published October 2022) looking at current research into the management of IgE-Mediated food allergy has made a positive conclusion about the therapies and care available to patients in future. Specifically, the article predicts that biologics may play a key role in the therapeutic options available and that identifying reliable biomarkers and developing standardised approaches could lead to individualised approaches to managing food allergy.